Clinical Trial

Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Investigating the efficacy of tranexamic acid (TXA) as a prophylactic agent in reducing postpartum haemorrhage (PPH) among patients undergoing cesarean section (CS) in SQUH: a prospective randomized controlled trial.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-03-10.
Trial Details
NCT Number NCT07474077
Lead Sponsor Sultan Qaboos University
Conditions Post Partum Haemorrhage
Enrollment 88 participants
Start Date 2026-05-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-01